National Bank Of Canada Genenta Science S.P.A. Transaction History
National Bank Of Canada
- $84.4 Billion
- Q3 2025
A detailed history of National Bank Of Canada transactions in Genenta Science S.P.A. stock. As of the latest transaction made, National Bank Of Canada holds 3,000 shares of GNTA stock, worth $6,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$6,600% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GNTA
# of Institutions
7Shares Held
552KCall Options Held
0Put Options Held
0-
Allianz Se Munich, 2M234KShares$514,9100.02% of portfolio
-
Al Ti Global, Inc. New York, NY200KShares$440,6330.01% of portfolio
-
Algebris (Uk) LTD London, X0100KShares$220,0000.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.5KShares$27,4690.0% of portfolio
-
Morgan Stanley New York, NY2.2KShares$4,8400.0% of portfolio
About Genenta Science S.p.A.
- Ticker GNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,216,900
- Market Cap $40.1M
- Description
- Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...